Skip to main content
SpringerLink
Log in

Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mazza P, Minoia C, Melpignano A (2016) The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a “real life” retrospective multicenter experience of the Rete Ematologica Pugliese (REP). Ann Hematol 95(2):239–244. doi:10.1007/s00277-015-2556-z

    Article  CAS  PubMed  Google Scholar 

  2. Kuter D, Bussel J, Lyons R (2008) Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomized controlled trial. Lancet 371:395–403

    Article  CAS  PubMed  Google Scholar 

  3. Bussel J, Provan D, Shamsi T (2009) Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomized, double-blind, placebo-controlled trial. Lancet 373:641–648

    Article  CAS  PubMed  Google Scholar 

  4. Rodeghiero F, Stasi R, Gernsheimer T (2009) Standarization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386–2393. doi:10.1182/blood-2008-07-162503

    Article  CAS  PubMed  Google Scholar 

  5. González-Porras J, Mingot-Castellano M, Andrade M (2014) Use of eltrombopag after romiplostim in primary immune thrombocytopenia. Br J Haematol. doi:10.1111/bjh.13266

  6. Aoki T, Harada Y, Matsubara E (2012) Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations. J Clin Pharm Ther. doi:10.1111/j.1365-2710-2012-01353.x

  7. Polverelli N, Palandri F, Iaocobucci I (2013) Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: possible role of MPL polymorphisms. Br J Haematol 161:136–153

    Article  Google Scholar 

  8. D´Arena G, Guariglia R, Mansueto G (2013) No cross-resistance after sequential use of romiplostim and eltrombopag in chronic immune thrombocytopenic pupura. Blood 121(7):1240–1241

    Article  Google Scholar 

  9. Tsukamoto S, Nakaseko C, Takeuchi M (2013) Safety and efficacy of romiplostim in patients with eltrombopag-resistant or intolerant immune thrombocytopenia. Br J Haematol 163:277–291

    PubMed  Google Scholar 

  10. Khellaf M, Viallard JF, Hamidou M (2013) A retrospective pilot evaluation of switching thrompoietic receptor-agonists in immune thrombocytopenia. Haematologica 98(6):881–887

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Hospital General Universitario de Valencia, Valencia, Spain

    Karla Javier González, Sebastian Ortiz Zuluaga, Carolina Villegas DaRos, Pedro Pérez Rodríguez & Antonio Cerveró Martí

Authors
  1. Karla Javier González
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sebastian Ortiz Zuluaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carolina Villegas DaRos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pedro Pérez Rodríguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antonio Cerveró Martí
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karla Javier González.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

González, K.J., Zuluaga, S.O., DaRos, C.V. et al. Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center. Ann Hematol 96, 507–508 (2017). https://doi.org/10.1007/s00277-016-2896-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-016-2896-3

Keywords

Search

Navigation